Search for: "Actavis plc" Results 1 - 20 of 72
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Mar 2014, 9:31 pm by Patent Docs
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
4 Apr 2014, 9:32 am by Gene Quinn
On March 19, 2014, Actavis plc (NYSE: ACT) announced that it entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis’ generic version of Daytrana® (Methylphenidate Transdermal System). [read post]
18 Nov 2013, 11:40 am by Gene Quinn
Actavis PLC (NYSE: ACT) recently filed an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
13 May 2014, 5:00 am by Gene Quinn
Actavis plc (NYSE: ACT) announced yesterday that it has entered into an agreement with Valeant Pharmaceuticals International (NYSE: VRX) to settle all outstanding patent litigation related to Actavis' generic version of Acanya®... [read post]
13 May 2014, 5:00 am by Gene Quinn
Actavis plc (NYSE: ACT) announced yesterday that it has entered into an agreement with Valeant Pharmaceuticals International (NYSE: VRX) to settle all outstanding patent litigation related to Actavis' generic version of Acanya®... [read post]
15 Nov 2015, 9:32 pm by Patent Docs
• Defendant: Actavis Laboratories FL, Inc.; Actavis, Inc.; Allergan PLC Infringement of U.S. [read post]
23 Apr 2016, 2:58 pm by Eric Needs
Companies including Purdue Pharma LP, Actavis PLC and Janssen Pharmaceuticals are asking the judgeThe post Drug Cos. [read post]
5 Apr 2015, 9:59 pm by Patent Docs
.; Actavis Inc.; Actavis plc Infringement of U.S. [read post]
30 Nov 2015, 6:11 am
The situation, which ultimately resulted in the acquisition of Allergan by Actavis plc, included a novel structure that involved a “partnership” between Valeant and the investment fund Pershing Square. [read post]
On November 17, 2014, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant Pharmaceuticals International Inc. [read post]
19 Apr 2015, 9:56 pm by Patent Docs
.; Actavis, PLC.; Allergan Sales, LLC Infringement of U.S. [read post]
14 Dec 2015, 1:32 pm by Anthony McCain
Actavis Art Gollwitzer: Texas Patent Law Landscape Is Changing Andrew Nusca: Should Apple Receive All Of Samsung’s Phone Profits Because Of A Patent? [read post]
8 Apr 2012, 8:51 pm by Patent Docs
Actavis Inc. et al. 1:12-cv-00323;... [read post]
13 Jul 2017, 3:21 am by tracey
Supreme Court O’Brien v Ministry of Justice [2017] UKSC 46 (12 July 2017) Walkerv Innospec Ltd & Ors [2017] UKSC 47 (12 July 2017) Eli Lilly v Actavis UK Ltd & Ors [2017] UKSC 48 (12 July 2017) Court of Appeal (Civil Division) S-F (A Child) [2017] EWCA Civ 964 (12 July 2017) P-K (Children) [2017] EWCA Civ 965 (12 July 2017) C (Children) [2017] EWCA Civ 980 (12 July 2017) High Court (Administrative Court) St Albans City And District Council, R (On the Application Of) v… [read post]
9 Jun 2016, 9:01 am by Robert Reznick
On Monday, June 7, the Supreme Court requested the views of the Solicitor General in connection with a petition for certiorari filed by the U.S. subsidiary of GlaxoSmithKline plc (“GSK”) in SmithKline Beecham Corp. v. [read post]
11 Apr 2016, 2:32 pm by Robert Reznick
  The FTC’s complaint attacks two such settlements that Endo Pharmaceuticals Inc. and the Japan-based patent holder for one of the relevant patents reached with generic manufacturers Watson Laboratories (and Watson’s current owner, Allergan plc) and Impax Laboratories, to settle Hatch-Waxman litigation involving Endo’s two most important products—the pain relievers Opana ER® and Lidoderm®.[2]  The FTC’s complaint, and its simultaneous… [read post]
29 Jun 2015, 9:36 am
A futuristic Neil imagines a time when consumers’ psychological/neurological associations could be measured (also) for the sake of assess a trade marks’ reputation* Case management decisions in the Lyrica caseThe ongoing case between Warner-Lambert (a subsidiary of Pfizer) and Actavis concerning pregabalin (sold by Pfizer under the trade mark Lyrica, and by Actavis under the trade mark Lecaent) seems set to be the case of the year, Darren says. [read post]
27 Sep 2017, 3:29 am
However, both these conclusions were rejected by the Supreme Court which found direct infringement of the Italian designation of the patent by the Actavis variants. [read post]